UAE Angiography Devices Market Analysis

The UAE Angiography Devices Market size stood at around xx Bn in 2023 and is projected to reach US $xx Bn by 2033, exhibiting a CAGR of xx% during the forecast period.

The UAE Angiography Devices Market Executive Summary

Angiography devices are specific diagnostic imaging systems that are employed in the depiction of blood vessels and organs with the primary use of X-ray Image Experience. He explains how these devices help in conducting angiogram, which is the process of taking images of blood vessels through injecting contrast dye into the vessels to make any blockage or irregularity visible on television monitor. The systems can display fluoroscopic views in real time and are important in diagnostic and interventional cardiology.

It holds a strategic position in medical diagnosis through angiography devices such as Digital Subtraction Angiography (DSA), Computed Tomography Angiography (CTA), Magnetic Resonance Angiography (MRA), and ultrasound. These devices are essential especially for conditions affecting the blood vessels and the nervous system. Market, factors include technological trends like the use of artificial intelligence, minimally invasive procedures, rising incidences of cardiovascular diseases, and heightened life expectancy. North America currently adopts a large market share and followed by Europe and Asia-Pacific with a rapidly growing market. Major players are GE Healthcare and Siemens Healthineers. They include high costs and regulatory constraints.    

UAE Angiography Devices Market Dynamics

Market Growth Drivers

A growing incidence of cardiovascular diseases, especially among the aging population, has led to a higher number of diagnostic and interventional procedures involving angiography technology. This is mainly because of the progressive improvements in the technological innovations utilized in such devices, thus expanding their utilization in healthcare facilities. Further, the minimally invasive treatments, which provide more rapid recovery, are gaining popularity in the global market for drivers and angiography devices. 

Opportunity

The angiography devices market also holds great potential for future growth in terms of entering markets that are currently in the development stage of their healthcare industry, and where the demand for angiography and other related technologies is rising rapidly. The integration of AI in angiography devices may improve diagnostic outcomes and allow for more patient-tailored therapies. Another opportunity is there existing a lucrative market in portable home-use devices for patients with chronic illnesses and those who cannot easily visit hospitals. 

Market Restraints

High and increasing prices for the equipment and the procedures; the use of radiation during the procedures and their higher availability in developed regions. Lack of sound reimbursement policies and scarcity of skilled workforce also inhibit adoption of HIE. In the same manner, there are some challenges associated with this technology whereby some new products may take longer to gain approval from the authorities which may slow down production and distribution of new products. 

Competitive Landscape for Angiography Devices Market in UAE

Key Players

• GE Healthcare
• Siemens Healthineers AG
• Boston Scientific Corporation
• Medtronic PLC
• Philips Healthcare
• AngioDynamics Inc.
• Shimadzu Corporation

Recent Developments

August 2024, Shimadzu Medical Systems USA introduced the Trinias angiography system at the SIR 2022 Annual Meeting. This system uses AI deep learning to enhance device visibility and reduce X-ray exposure by over 40% compared to previous models. It is the first angiography system to incorporate AI into its image processing engine.

October 2023, Abbott launched new vascular imaging platform in India. Unlike traditional imaging methods such as conventional angiography, the intravascular imaging software uses near- infrared light to provide high-definition, precise imaging from within blood vessels, allowing physicians to capture information from even the most complex patient anatomy.

September 2022, Siemens Healthineers launched angiography system, ARTIS icono in India. The new ARTIS icono systems adapt flexibly to the differing needs of cardiovascular interventions, interventional radiology, neuroradiology, and vascular interventions.  

June 2022, Shimadzu Corporation announced the commencement of worldwide sales of the newest version of the company’s Trinias angiography system. Shimadzu Medical Systems USA introduced the new system at the SIR 2022 annual scientific meeting held June 11-16 in Boston, Massachusetts.

Mergers and Acquisitions

June 2024, Silk Road Medical, Inc., a leading minimally invasive medical device company for carotid artery procedures, announced today it has entered into a definitive agreement to be acquired by Boston Scientific Corporation, a global medical technology leader, for $27.50 in cash per share, representing an equity value of approximately $1.26 billion.

March 2024, Titan Medical Inc. announced that it has entered into a definitive amalgamation agreement dated March 17, 2024 with Conavi Medical Inc. to combine the companies in an all-stock transaction. The combined company will focus on continuing to commercialize Conavi’s Novasight Hybrid System designed to guide common minimally invasive coronary procedures.

November 2023, Johnson & Johnson MedTech Acquires Laminar, Inc. Innovative investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation.

Healthcare Policies and Regulatory Landscape for Angiography Devices Market in UAE

Policy changes and Reimbursement scenario

Government initiatives across countries especially in north America such as low tax incentives and favourable policy environment also the recent ease in the regulatory frameworks in areas of Europe including Germany are also driving the advancements of angiography technologies. There has also been a shift toward less invasive treatments, which is also spurring adoption of these devices. Reimbursement policies, especially in North American region which most of its procedures are reimbursable by Medicare and private insurance companies are the primary drivers of the market. However, this variability in reimbursement rates across regions may affect the adoption of the technology especially in developing markets where health coverage and system are still being established.